ME
McIlrath & Eck’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.36K | Hold |
43
| – | – | ﹤0.01% | 716 |
|
|
2025
Q1 | $5.84K | Hold |
43
| – | – | ﹤0.01% | 694 |
|
|
2024
Q4 | $6.53K | Hold |
43
| – | – | ﹤0.01% | 704 |
|
|
2024
Q3 | $8.27K | Hold |
43
| – | – | ﹤0.01% | 666 |
|
|
2024
Q2 | $9.89K | Sell |
43
-6
| -12% | -$1.38K | ﹤0.01% | 603 |
|
|
2024
Q1 | $10.6K | Sell |
49
-1
| -2% | -$217 | ﹤0.01% | 591 |
|
|
2023
Q4 | $12.9K | Hold |
50
| – | – | ﹤0.01% | 511 |
|
|
2023
Q3 | $12.9K | Sell |
50
-6
| -11% | -$1.54K | ﹤0.01% | 500 |
|
|
2023
Q2 | $16K | Hold |
56
| – | – | ﹤0.01% | 458 |
|
|
2023
Q1 | $15.6K | Hold |
56
| – | – | ﹤0.01% | 456 |
|
|
2022
Q4 | $15.5K | Hold |
56
| – | – | ﹤0.01% | 454 |
|
|
2022
Q3 | $15K | Hold |
56
| – | – | ﹤0.01% | 448 |
|
|
2022
Q2 | $11K | Hold |
56
| – | – | ﹤0.01% | 494 |
|
|
2022
Q1 | $12K | Hold |
56
| – | – | ﹤0.01% | 496 |
|
|
2021
Q4 | $13K | Hold |
56
| – | – | ﹤0.01% | 489 |
|
|
2021
Q3 | $16K | Hold |
56
| – | – | ﹤0.01% | 431 |
|
|
2021
Q2 | $19K | Hold |
56
| – | – | 0.01% | 394 |
|
|
2021
Q1 | $16K | Buy |
+56
| New | +$16K | 0.01% | 378 |
|
|
2019
Q3 | – | Sell |
-18
| Closed | -$4K | – | 624 |
|
|
2019
Q2 | $4K | Hold |
18
| – | – | ﹤0.01% | 480 |
|
|
2019
Q1 | $4K | Hold |
18
| – | – | ﹤0.01% | 480 |
|
|
2018
Q4 | $5K | Hold |
18
| – | – | ﹤0.01% | 361 |
|
|
2018
Q3 | $6K | Hold |
18
| – | – | ﹤0.01% | 353 |
|
|
2018
Q2 | $5K | Hold |
18
| – | – | ﹤0.01% | 358 |
|
|
2018
Q1 | $5K | Hold |
18
| – | – | ﹤0.01% | 341 |
|
|
2017
Q4 | $6K | Buy |
+18
| New | +$6K | ﹤0.01% | 334 |
|